SGMO Projected Dividend Yield
Sangamo Therapeutics Inc ( NASDAQ : SGMO )Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. Co.'s neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended neurological targets. Co.'s zinc finger epigenetic regulators are ideally suited to potentially address neurological disorders and its capsid discovery platform is expanding delivery beyond intrathecal delivery capsids, including in the central nervous system. 21 YEAR PERFORMANCE RESULTS |
SGMO Dividend History Detail SGMO Dividend News SGMO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |